Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions

Journal of the American Medical Informatics Association

Volumn 18, Issue 1, 2011, Pages 32-37

  Saverno, Kim R ^a   Hines, Lisa E ^a   Warholak, Terri L ^a   Grizzle, Amy J ^a   Babits, Lauren ^a   Clark, Courtney ^a   Taylor, Ann M ^a   Malone, Daniel C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; AMOXICILLIN; CARBAMAZEPINE; CLARITHROMYCIN; CODEINE; COTRIMOXAZOLE; DIGOXIN; ERYTHROMYCIN; FLUCONAZOLE; GEMFIBROZIL; GLYCERYL TRINITRATE; ITRACONAZOLE; METFORMIN; NAPROXEN; PARACETAMOL; PRAVASTATIN; SILDENAFIL; SIMVASTATIN; WARFARIN;

ARTICLE; CLINICAL DECISION MAKING; COMPUTER PROGRAM; COMPUTER SYSTEM; DECISION SUPPORT SYSTEM; EVALUATION; HUMAN; INFORMATION SYSTEM; PHARMACIST; PHARMACY; PREDICTIVE VALUE; PRESCRIPTION; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; UNITED STATES;

ARIZONA; CLINICAL PHARMACY INFORMATION SYSTEMS; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG INTERACTIONS; HEALTH CARE SURVEYS; HUMANS; MEDICATION ERRORS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SOFTWARE VALIDATION;

EID: 78650477297     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/jamia.2010.007609     Document Type: Article

References (45)

1. Committee on Identifying and Preventing Medication Errors. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academies Press, 2007.
2. Glassman PA, Simon B, Belperio P, et al. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care 2002;40:1161-71.
3. Ko Y, Malone DC, Skrepnek GH, et al. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers. Drug Saf 2008;31:525-36.
4. Ko Y, Abarca J, Malone DC, et al. Practitioners' views on computerized drug-drug interaction alerts in the VA system. J Am Med Inform Assoc 2007;14:56-64.
5. Weideman RA, Bernstein IH, McKinney WP. Pharmacist recognition of potential drug interactions. Am J Health Syst Pharm 1999;56:1524-9.
6. Abarca J, Colon LR, Wang VS, et al. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. J Manag Care Pharm 2006;12:383-9.
7. Hazlet TK, Lee TA, Hansten PD, et al. Performance of community pharmacy drug interaction software. J Am Pharm Assoc (Wash) 2001;41:200-4.
8. Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 2006;13:5-11.
9. van der Sijs H, Aarts J, Vulto A, et al. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006;13:138-47.
10. Abarca J, Malone DC, Skrepnek GH, et al. Community pharmacy managers' perception of computerized drug-drug interaction alerts. J Am Pharm Assoc (2003) 2006;46:148-53.
11. Cash JJ. Alert fatigue. Am J Health Syst Pharm 2009;66:2098-101.
12. Chaffee BW. Future of clinical decision support in computerized prescriber order entry. Am J Health Syst Pharm 2010;67:932-5.
13. Chrischilles EA, Fulda TR, Byrns PJ, et al. The role of pharmacy computer systems in preventing medication errors. J Am Pharm Assoc (Wash) 2002;42:439-48.
14. Chui MA, Rupp MT. Evalutaion of online prospective DUR programs in community pharmacy practice. J Manag Care Pharm 2000;6:27-32.
15. Murphy JE, Forrey RA, Desiraju U. Community pharmacists' responses to drug-drug interaction alerts. Am J Health Syst Pharm 2004;61:1484-7.
16. National Association of Chain Drug Stores, Inc. 2009. http://www.nacds.org/ wmspage.cfm?parm1=6421.
17. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (2003) 2004;44:142-51.
18. Malone DC, Hutchins DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health Syst Pharm 2005;62:1983-91.
19. Drug Interaction Facts. St Louis, MO: Wolters Kluwer Health, 2008.
20. Hansten PD, Horn JR. Drug Interactions Analysis and Management. St Louis, MO: Wolters Kluwer Health, 2008.
21. Hansten PD, Horn JR. The Top 100 Drug Interactions. A Guide to Patient Management. 2008 edn. Freeland, WA: H&H Publications, LLP, 2008.
22. Baxter K, ed, Stockley's Drug Interactions 8 [CD-ROM]. London: Pharmaceutical Press, 2008.
23. Cone LA, Himelman RB, Hirschberg JN, et al. Itraconazole-related amaurosis and vomiting due to digoxin toxicity. West J Med 1996;165:322.
24. Jalava KM, Partanen J, Neuvonen PJ. Itraconazole decreases renal clearance of digoxin. Ther Drug Monit 1997;19:609-13.
25. Partanen J, Jalava KM, Neuvonen PJ. Itraconazole increases serum digoxin concentration. Pharmacol Toxicol 1996;79:274-6.
26. Kauffman CA, Bagnasco FA. Digoxin toxicity associated with itraconazole therapy. Clin Infect Dis 1992;15:886-7.
27. Lopez F, Hancock EW. Nausea and malaise during treatment of coccidioidomycosis. Hosp Pract (Minneap) 1997;32:21-2.
28. McClean KL, Sheehan GJ. Interaction between itraconazole and digoxin. Clin Infect Dis 1994;18:259-60.
29. Rex J. Itraconazoleedigoxin interaction. Ann Intern Med 1992;116:525.
30. Sachs MK, Blanchard LM, Green PJ. Interaction of itraconazole and digoxin. Clin Infect Dis 1993;16:400-3.
31. Clinical Decision Support Workshop Meeting Summary: August 25-26, 2009. Washington, DC: Office of the National Coordinator for Health Information Technology, Department of Health & Human Services, 2010. http://healthit.hhs.gov/ portal/server.pt/gateway/PTARGS_0_11113_898639_0_0_18/ONC%20CDS% 20Workshop%20Meeting%20Summary_f.pdf.
32. Metzger J, Welebob E, Bates DW, et al. Mixed results in the safety performance of computerized physician order entry. Health Aff (Millwood) 2010;29:655-9.
33. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996;275:1086-7.
34. Horn JR, Hansten PD. Reducing drug interaction alerts: not so easy. Pharmacy Times June 2007:34.
35. Institute for Safe Mediction Practices. Heed this Warning! Don't Miss Important Computer Alerts. ISMP Med Saf Alert. 2007; 12(3);1-2. 2010. http://www.ismp.org/ newsletters/acutecare/archives/NL_20070208.pdf.
36. Payne TH, Nichol WP, Hoey P, et al. Characteristics and override rates of order checks in a practitioner order entry system. Proc AMIA Symp 2002:602-6.
37. Weingart SN, Toth M, Sands DZ, et al. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-31.
38. Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009;169:305-11.
39. Magnus D, Rodgers S, Avery AJ. GPs' views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002;27:377-82.
40. Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc (2003). 2004;44:136-41.
41. Pham PA. Drugedrug interaction programs in clinical practice. Clin Pharmacol Ther 2008;83:396-8.
42. Fulda TR, Baluck R, Vander zanden J, et al. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr Ther Res Clin Exp 2000;61:540-8.
43. Kuperman GJ, Reichley RM, Bailey TC. Using commercial knowledge bases for clinical decision support: opportunities, hurdles, and recommendations. J Am Med Inform Assoc 2006;13:369-71.
44. Reichley RM, Seaton TL, Resetar E, et al. Implementing a commercial rule base as a medication order safety net. J Am Med Inform Assoc 2005;12:383-9.
45. Miller RA, Gardner RM, Johnson KB, et al. Clinical decision support and electronic prescribing systems: a time for responsible thought and action. J Am Med Inform Assoc 2005;12:403-9.